بررسی فراوانی کووید-19 در مبتلایان به آرتریت روماتوئید: یک مطالعه مقطعی

Bagheri SF, Saeedi M, Savabi NV, Deldari AM, Ghodrat G, FATHI AA. Anxiety, Depression and Stress in Patients with Rheumatoid Arthritis and Migraine During Coronavirus 2019 Pandemic: Systematic Review Study.2022.

Moreno-Eutimio MA, Lopez-Macias C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes and Infection 2020;22:226-9. doi: 10.1016/j.micinf.2020.04.009

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. doi: 10.1001/jama.2020.2648

Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy 2020;75:1730-41. doi: 10.1111/all.14238

Conigliaro P, Triggianese P, De Martino E, Fonti GL, Chimenti MS, Sunzini F, et al. Challenges in the treatment of rheumatoid arthritis. Autoimmunity Reviews 2019;18:706-13. doi: 10.1016/j.autrev.2019.05.007

Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population‐based study. Arthritis and Rheumatism 2002;46:2287-93. doi: 10.1002/art.10524

Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Annals of the Rheumatic Diseases 2007;66:308-12. doi: 10.1136/ard.2006.057265

Koppert TY, Jacobs JW, Geenen R. The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease. Rheumatology 2021;60:3709-15.

doi: 10.1093/rheumatology/keaa842

Organization WH. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization; 2020.

Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, et al. COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. The Lancet Rheumatology 2022;4:e310-e3. doi: 10.1016/S2665-9913(22)00009-1

Sen P, Ravichandran N, Nune A, Lilleker JB, Agarwal V, Kardes S, et al. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study. Rheumatology 2023;62:65-76. doi: 10.1093/rheumatology/keac305

Baillet A, Gossec L, Carmona L, de Wit M, van Eijk-Hustings Y, Bertheussen H, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Annals of the Rheumatic Diseases 2016;75:965-73. doi: 10.1136/annrheumdis-2016-209233

Wang Y, D'Silva KM, Jorge AM, Li X, Lyv H, Wei J, et al. Increased Risk of COVID-19 in Patients With Rheumatoid Arthritis: A General Population-Based Cohort Study. Arthritis Care Res (Hoboken) 2022;74:741-7. doi: 10.1002/acr.24831

Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology 2013;52:53-61. doi: 10.1093/rheumatology/kes305

D'Silva KM, Wallace ZS. COVID-19 and rheumatoid arthritis. Current Opinion in Rheumatology 2021;33. doi: 10.1097/BOR.0000000000000786

England BR, Roul P, Yang Y, Kalil AC, Michaud K, Thiele GM, et al. Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals. Arthritis Rheumatol 2021;73:2179-88. doi: 10.1002/art.41800

Assar S, Mohamadzadeh D, Pournazari M, Soufivand P. Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases. The Egyptian Rheumatologist 2022;44:209-13. doi: 10.1016/j.ejr.2021.12.002

Montero F, Martínez-Barrio J, Serrano-Benavente B, González T, Rivera J, Molina Collada J, et al. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatology International 2020;40:1593-8. doi: 10.1007/s00296-020-04676-4

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 2020;382:1708-20. doi: 10.1056/NEJMoa2002032

Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine 2020;8:475-81. doi: 10.1016/S2213-2600(20)30079-5

Kalra RS, Tomar D, Meena AS, Kandimalla R. SARS-CoV-2, ACE2, and hydroxychloroquine: cardiovascular complications, therapeutics, and clinical readouts in the current settings. Pathogens 2020;9:546. doi: 10.3390/pathogens9070546

Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nature Reviews Rheumatology 2020;16:465-70. doi: 10.1038/s41584-020-0451-z

Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clinical Immunology 2020;215:108410. doi: 10.1016/j.clim.2020.108410

Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. New England Journal of Medicine 2020;382:e38. doi: 10.1056/NEJMc2007575

Topless RK, Phipps‐Green A, Leask M, Dalbeth N, Stamp LK, Robinson PC, et al. Gout, rheumatoid arthritis, and the risk of death related to coronavirus disease 2019: an analysis of the UK Biobank. ACR Open Rheumatology 2021;3:333-40. doi: 10.1002/acr2.11252

Tan EM, Smolen JS. Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. Journal of Experimental Medicine 2016;213:1937-50. doi: 10.1084/jem.20160792

van Venrooij WJ, Pruijn GJ. An important step towards completing the rheumatoid arthritis cycle. Arthritis Research & Therapy 2008;10:117. doi: 10.1186/ar2504

Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy 2008;10:R94. doi: 10.1186/ar2478

Kasiraja V, Bakar NAA, Suliman NA. Rheumatoid arthritis unmasked: the immune complex as a key driver of disease progression. Exploration of Immunology 2025;5:1003208. doi: 10.37349/ei.2025.1003208

Ajeganova S, Huizinga TW. Seronegative and seropositive RA: alike but different? Nature Reviews Rheumatology 2015;11:8-9. doi: 10.1038/nrrheum.2014.194

Khoja SS, Moore CG, Goodpaster BH, Delitto A, Piva SR. Skeletal muscle fat and its association with physical function in rheumatoid arthritis. Arthritis Care and Research 2018;70:333-42. doi: 10.1002/acr.23278

Akhlaghi M, Askarishahi M, Sabzmakan L. Quality of life and related factors in rheumatoid arthritis patients. Journal of Health Research in Community 2016;2:1-11.

Naqvi AA, Hassali MA, Aftab MT, Naqvi SBS, Zehra F, Ahmad R, et al. Development of evidence-based disease education literature for Pakistani rheumatoid arthritis patients. Diseases 2017;5:27. doi: 10.3390/diseases5040027

Gravallese EM, Firestein GS. Rheumatoid Arthritis-Common Origins, Divergent Mechanisms. New England Journal of Medicine 2023;388:529-42. doi: 10.1056/NEJMra2103726